Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
3.7550
-0.2500
(-6.24%)
At close: February 21 at 3:29:01 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-32,784
-31,809
-37,645
-15,062
-8,847
Investing Cash Flow
-967
-37
-117
--
-42
Financing Cash Flow
44,963
27,500
17,018
51,183
17,182
End Cash Position
20,157
21,668
26,013
46,758
10,637
Capital Expenditure
--
--
-64
--
--
Issuance of Capital Stock
47,201
17,809
17,870
55,148
17,996
Issuance of Debt
--
10,000
--
--
--
Free Cash Flow
-33,573
-31,809
-37,709
-15,062
-8,847
12/31/2020 - 3/11/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
600161.SS TIANTAN BIO
20.05
-0.35%
RGO.DU Regeneron Pharmaceuticals Inc
657.40
+1.20%
PH4.F CStone Pharmaceuticals
0.3720
+4.49%
HQ1.MU Oruka Therapeutics Inc. R
10.60
+0.95%
GYX.F Futura Medical plc
0.1770
+14.94%
BSSP Baseline Productions, Inc.
0.0001
0.00%
10VA.F Immunic, Inc.
1.2360
+14.98%
49BA.SG BeiGene Ltd
248.00
+9.73%
2563.HK Beijing Biostar Pharms Co Ltd
17.680
-1.78%
MBXBF Microbix Biosystems Inc.
0.3470
+2.06%